Mesenteric Infiltration in Ovarian Cancer

Recruiting now

Conditions studied: Ovary Cancer

In brief

To evaluate if CT features at diagnosis in patients with HGSOC can be used to build an Artificial Intelligence model capable of discerning the pathological involvement of the mesentery, assessing the potential impediments for an optimal debulking surgery and predicting the development of resistance to platinum based chemotherapeutic agents.

Key facts

Study ID

NCT06331130

Run by

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

People needed

510

Starts

2024-03-01

Expected to finish

2025-12-31

Last updated by the study team

2025-03-12

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women with confirmed HGSOC wiht mesenteric involvment
• Age > 18 years
• FIGO STAGE IIIB-IV
• Primary diagnosis
• Signed informed consent

You may not qualify if…

• Non-serous high grade epithelial ovarian cancer (serous low grade, mucinous, clear cell carcinoma, endometrioid or non-epithelial ovarian cancer)
• Early stage disease (I and II stage)
• CT scan not available
• Non-primary diagnosis or patient subjected to neoadjuvant chemotherapy

Where it is running

• Advanced Radiology Center — Roma, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.